This announcement is a separate document:
南京证券股份有限公司关于江苏诺泰澳赛诺生物制药股份有限公司使用部分募集资金向全资子公司增资用于实施募投项目的核查意见
Opinion on verification of Jiangsu Notai Ausanuo Biopharmaceutical Co., Ltd.'s use of part of the raised funds to increase capital to fully-owned subsidiaries for the implementation of the raised investment project by Nanjing Securities Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.